APC(Cdc20) Suppresses Apoptosis Through Targeting Bim for Ubiquitination and Destruction.
Lixin Wan,Mingjia Tan,Jie Yang,Hiroyuki Inuzuka,Xiangpeng Dai,Tao Wu,Jia Liu,Shavali Shaik,Guoan Chen,Jing Deng,Marcos Malumbres,Anthony Letai,Marc W Kirschner,Yi Sun,Wenyi Wei
DOI: https://doi.org/10.1016/j.devcel.2014.04.022
IF: 13.417
2014-01-01
Developmental Cell
Abstract:Anaphase-promoting complex Cdc20 (APC(Cdc20)) plays pivotal roles in governing mitotic progression. By suppressing APC(Cdc20), antimitotic agents activate the spindle-assembly checkpoint and induce apoptosis after prolonged treatment, whereas depleting endogenous Cdc20 suppresses tumorigenesis in part by triggering mitotic arrest and subsequent apoptosis. However, the molecular mechanism(s) underlying apoptosis induced by Cdc20 abrogation remains poorly understood. Here, we report the BH3-only proapoptotic protein Bim as an APC(Cdc20) target, such that depletion of Cdc20 sensitizes cells to apoptotic stimuli. Strikingly, Cdc20 and multiple APC-core components were identified in a small interfering RNA screen that, upon knockdown, sensitizes otherwise resistant cancer cells to chemoradiation in a Bim-dependent manner. Consistently, human adult T cell leukemia cells that acquire elevated APC(Cdc20) activity via expressing the Tax viral oncoprotein exhibit reduced Bim levels and resistance to anticancer agents. These results reveal an important role for APC(Cdc20) in governing apoptosis, strengthening the rationale for developing specific Cdc20 inhibitors as effective anticancer agents.